RIBAVIRIN and PYREXIA

Overview

PYREXIA is the #10 most commonly reported adverse reaction for RIBAVIRIN, manufactured by Bausch Health US, LLC. There are 3,581 FDA adverse event reports linking RIBAVIRIN to PYREXIA. This represents approximately 2.3% of all 157,291 adverse event reports for this drug.

RIBAVIRIN has an overall safety score of 85 out of 100. Patients taking RIBAVIRIN who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for RIBAVIRIN, but still significant enough to appear in the safety profile.

Other Side Effects of RIBAVIRIN

In addition to pyrexia, the following adverse reactions have been reported for RIBAVIRIN:

• FATIGUE — 9,551 reports
• ANAEMIA — 8,365 reports
• NAUSEA — 7,421 reports
• RASH — 5,358 reports
• HEADACHE — 4,783 reports
• PRURITUS — 4,636 reports
• VOMITING — 3,806 reports
• DIARRHOEA — 3,739 reports
• ASTHENIA — 3,613 reports
• WHITE BLOOD CELL COUNT DECREASED — 3,443 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does RIBAVIRIN cause PYREXIA?

PYREXIA has been reported as an adverse event in 3,581 FDA reports for RIBAVIRIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with RIBAVIRIN?

PYREXIA accounts for approximately 2.3% of all adverse event reports for RIBAVIRIN, making it a notable side effect.

What should I do if I experience PYREXIA while taking RIBAVIRIN?

If you experience pyrexia while taking RIBAVIRIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages